Log In
Print
BCIQ
Print
Print this Print this
 

NuThrax (AV7909)

  Manage Alerts
Collapse Summary General Information
Company Emergent BioSolutions Inc.
DescriptionThird generation anthrax vaccine that consists of BioThrax, an adsorbed anthrax vaccine, and CPG 7909, an immunostimulatory compound
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationAnthrax
Indication DetailsPrevent anthrax infection
Regulatory Designation

U.S. - Fast Track (Prevent anthrax infection)

Partner

Pfizer Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today